Laryxin

Chlorhexidine gluconate, the active ingredient in Laryxin, is an antiseptic presented as an oral solution for oromucosal use. It provides broad‑spectrum antimicrobial action and, together with lidocaine hydrochloride, offers local pain relief for oral mucosal irritation, sore throat and ulcerative lesions in adults and children.

GNH USA supplies Laryxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and ensuring reliable global distribution.

Laryxin combines an antiseptic and a local anesthetic to address conditions affecting the oral mucosa.

- Oral mucosal antisepsis: reduces bacterial load and helps prevent infection in the mouth. - Sore throat relief: numbs the throat lining to alleviate pain associated with pharyngitis. - Oral ulcer pain management: provides temporary analgesia for aphthous ulcers and other oral lesions.

Laryxin may cause a range of adverse reactions, from mild and transient to rare serious events.

Common Side Effects: - Altered taste sensation: temporary metallic or bitter taste. - Oral irritation: mild burning or tingling at the site. - Transient numbness: short‑lasting loss of feeling in the mouth.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or hives. - Anaphylaxis: severe, potentially life‑threatening hypersensitivity. - Severe mucosal ulceration: unexpected worsening of oral lesions.

When using Laryxin, consider the following precautions to ensure safe and effective treatment.

- Allergy assessment: avoid use in patients with known hypersensitivity to chlorhexidine or lidocaine. - Lesion limitation: do not apply to extensive open wounds or deep oral ulcers. - Duration of use: limit treatment to the shortest period necessary, typically not exceeding 7 days without medical advice. - Concurrent eye exposure: keep product away from eyes; immediate irrigation if contact occurs. - Pregnancy and lactation: consult a healthcare professional before use during pregnancy or breastfeeding. - Store at room temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Laryxin can interact with other medications or products; awareness of these interactions helps minimize risk.

Major Interactions (Avoid): - Concurrent use with other chlorhexidine products: may increase local irritation. - Simultaneous application of other topical anesthetics: risk of additive numbness and systemic toxicity.

Moderate Interactions (Monitor Closely): - Alcohol‑based mouthwashes: can enhance oral irritation. - Systemic local anesthetics (e.g., oral lidocaine tablets): monitor for cumulative sodium channel blockade. - Antihistamines: may mask early signs of allergic reactions.